Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung Cancer
Clinical trial NCT01951690 · COMPLETED
Trial details
- NCT number
- NCT01951690
- Sponsor
- Verastem, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2016-06-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.